Ftse Mib
36.434,15
0,17%
DAX
21.727,20
0,48%
S&P 500
6.070,01
0,51%
NASDAQ
19.621,63
-0,05%
Bitcoin
105.457,93
1,66%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Eliem Therapeutics Inc (ELYM) Eliem Therapeutics Inc (ELYM) Notizie

Eliem Therapeutics Inc

ELYM
5,11
0,00 (0,00%)
Ultimo aggiornamento: 01:00:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/1/202522:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/1/202522:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202514:08EDGAR2Form 8-K - Current report
20/12/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
14/11/202415:29EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
12/11/202422:51EDGAR2Form S-3 - Registration statement under Securities Act of..
12/11/202422:05EDGAR2Form 8-K - Current report
15/10/202413:08EDGAR2Form 8-K - Current report
02/10/202422:15EDGAR2Form 8-K - Current report
02/10/202415:00GLOBEEliem Therapeutics Announces Rebranding and Corporate Name..
21/9/202403:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202413:00GLOBEEliem Therapeutics to Participate at the Stifel 2024 Virtual..
27/8/202423:21EDGAR2Form 8-K - Current report
26/8/202423:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202423:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
26/8/202413:07EDGAR2Form 8-K - Current report
26/8/202413:00GLOBEEliem Therapeutics Announces Additions to its Leadership..
16/8/202422:23EDGAR2Form SC 13D/A - General Statement of Acquisition of..
14/8/202422:05EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/8/202412:10EDGAR2Form 8-K - Current report
14/8/202412:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202412:05GLOBEEliem Therapeutics Reports Second Quarter Financial Results
23/7/202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/7/202422:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19/7/202417:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202400:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202400:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202422:17EDGAR2Form S-3 - Registration statement under Securities Act of..
12/7/202402:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/7/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202413:00GLOBEEliem Therapeutics Announces its Addition to the Russell..
27/6/202422:01GLOBEEliem Therapeutics Announces the Closing of its Acquisition..
14/6/202423:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/6/202422:42EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/6/202422:41EDGAR2Form 8-K - Current report
04/6/202414:00EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
17/5/202422:36EDGAR2Form PREM14A - Preliminary proxy statements relating to..
17/5/202422:01EDGAR2Form SC 13D/A - General statement of acquisition of..
15/5/202412:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202400:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/4/202422:27PRNUSKuehn Law Encourages ALPN, JBT, ELYM, and HRT Investors to..
11/4/202413:00GLOBEEliem Therapeutics Announces Agreement to Acquire Tenet..
04/3/202417:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 5,11

La tua Cronologia

NASDAQ
ELYM
Eliem Therapeutics
ASX
TTL
Transcendence Technologies
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci